THC Biomed Financials
| THCBF Stock | USD 0 0.00 0.00% |
THC |
THC Biomed Stock Summary
THC Biomed competes with Earth Science, Im Cannabis, and Medicure. THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2550 Acland Road, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | thcbiomed.com |
| Currency | USD - US Dollar |
THC Biomed Key Financial Ratios
There are many critical financial ratios that THC Biomed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that THC Biomed Intl reports annually and quarterly.THC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining THC Biomed's current stock value. Our valuation model uses many indicators to compare THC Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across THC Biomed competition to find correlations between indicators driving THC Biomed's intrinsic value. More Info.THC Biomed Intl is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the THC Biomed's earnings, one of the primary drivers of an investment's value.THC Biomed Intl Systematic Risk
THC Biomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. THC Biomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on THC Biomed Intl correlated with the market. If Beta is less than 0 THC Biomed generally moves in the opposite direction as compared to the market. If THC Biomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one THC Biomed Intl is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of THC Biomed is generally in the same direction as the market. If Beta > 1 THC Biomed moves generally in the same direction as, but more than the movement of the benchmark.
THC Biomed January 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of THC Biomed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of THC Biomed Intl. We use our internally-developed statistical techniques to arrive at the intrinsic value of THC Biomed Intl based on widely used predictive technical indicators. In general, we focus on analyzing THC Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build THC Biomed's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 95.92 |
Complementary Tools for THC Pink Sheet analysis
When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |